quantitative
Analysis v1
Strong Support

Semaglutide might be better than other similar weight-loss drugs at protecting heart health in people who are overweight or obese but don’t have diabetes.

65
Pro
0
Against

Evidence from Studies

Supporting (1)

65

Community contributions welcome

The study looked at weight-loss drugs called GLP-1 agonists in people who are overweight but don’t have diabetes, and found that semaglutide works better than the others at lowering heart risks.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.